​

Kiniksa Pharmaceuticals International Ownership | Who Owns Kiniksa Pharmaceuticals International?


OverviewForecastRevenueFinancialsChartTranscripts

Kiniksa Pharmaceuticals International Ownership Summary


Kiniksa Pharmaceuticals International is owned by 61.05% institutional investors, 3.46% insiders, and 35.50% retail investors. Fmr is the largest institutional shareholder, holding 9.65% of KNSA shares. Vanguard MStar Total Stk Mkt Idx Invest is the top mutual fund, with 1.78% of its assets in Kiniksa Pharmaceuticals International shares.

KNSA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockKiniksa Pharmaceuticals International61.05%3.46%35.50%
SectorHealthcare Stocks 128.69%12.02%-40.72%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr7.49M9.65%$558.63M
Rubric capital management lp4.00M5.23%$255.79M
Vanguard group3.11M4.23%$128.41M
Blackrock funding, inc. /de2.94M3.79%$219.63M
Baker bros. advisors lp2.83M3.70%$181.28M
Tang capital management2.26M2.95%$144.52M
Vanguard portfolio management2.03M2.62%$151.51M
Vanguard capital management1.43M1.85%$106.97M
Arrowstreet capital, limited partnership1.09M1.41%$81.62M
Morgan stanley936.37K1.21%$69.86M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Spruce street capital lp918.07K10.89%$68.50M
Tang capital management2.26M6.56%$144.52M
Lion point capital, lp23.40K5.16%$908.62K
Lisanti capital growth129.25K2.59%$9.64M
Rubric capital management lp4.00M2.35%$255.79M
Stempoint capital lp209.23K2.30%$13.38M
Essex investment management202.02K2.23%$15.07M
Rice hall james & associates624.93K1.95%$39.96M
Penn capital management company347.66K1.89%$25.97M
Baker bros. advisors lp2.83M0.91%$181.28M

Top Buyers

HolderShares% AssetsChange
Clearbridge investments595.41K0.04%595.41K
Fmr7.49M0.02%516.03K
Ubs group374.34K0.00%329.17K
Janus henderson group481.02K0.01%327.60K
Northern trust315.25K0.00%278.32K

Top Sellers

HolderShares% AssetsChange
Blackrock---4.19M
Hhlr advisors---1.58M
Fairmount funds management---1.32M
Nuveen asset management---831.10K
Millennium management93.36K0.00%-471.06K

New Positions

HolderShares% AssetsChangeValue
Clearbridge investments595.41K0.04%595.41K$44.42M
Lord, abbett254.45K0.06%254.45K$18.98M
Stempoint capital lp209.23K2.30%209.23K$13.38M
Mufg securities emea150.00K0.12%150.00K$11.19M
Ranger investment management102.53K0.72%102.53K$7.65M

Sold Out

HolderChange
Twin peaks wealth advisors-1.00
Fiduciary financial advisors-4.00
Advisory services network-8.00
Optima capital-18.00
Riggs asset managment-30.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202631213.04%47,357,2950.62%611.61%18917.39%843.70%
Jun 30, 202627417.09%47,017,9873.55%611.64%15835.04%82-5.75%
Mar 31, 2026144-36.28%15,964,705-62.83%210.63%77-35.29%47-32.86%
Dec 31, 202561-70.67%7,296,166-82.12%90.32%27-74.53%19-72.86%
Sep 30, 202571-62.83%6,310,956-84.11%80.29%41-63.06%20-67.74%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard MStar Total Stk Mkt Idx Invest1.39M1.78%69.54K
Vanguard US Total Market Shares ETF1.25M1.72%-
Vanguard Total Stock Mkt Idx Inv1.32M1.71%21.86K
Vanguard Morn Total Stk Mkt Idx Investor1.32M1.69%21.86K
iShares Russell 2000 ETF1.16M1.47%-
Pictet Biotech965.39K1.36%965.39K
Vanguard Small Cap Index978.74K1.25%20.50K
Fidelity Select Health Care970.00K1.24%50.00K
Strategic Advisers Fidelity US TtlStk761.82K0.97%85.68K
Fidelity Select Biotechnology637.60K0.82%-

Recent Insider Transactions


DateNameRoleActivityValue
Nov 09, 2026Megna Michael R CHIEF ACCOUNTING OFFICERSell$1.11M
Nov 04, 2026Patel Sanj K CHAIRMAN & CEOSell$2.85M
Nov 04, 2026Patel Sanj K CHAIRMAN & CEOSell$134.83K
Nov 04, 2026Patel Sanj K CHAIRMAN & CEOSell$1.06M
Nov 04, 2026Patel Sanj K CHAIRMAN & CEOSell$7.70M

Insider Transactions Trends


DateBuySell
2026 Q4-52
2026 Q3-2
2026 Q2-14
2026 Q1-12
2025 Q4-17

KNSA Ownership FAQ


Who owns the most shares of Kiniksa Pharmaceuticals International?

Kiniksa Pharmaceuticals International’s largest shareholders are Fmr (7.49M shares, 9.65%), Rubric capital management lp (4M shares, 5.23%), and Vanguard group (3.11M shares, 4.23%). Together, they hold 19.11% of Kiniksa Pharmaceuticals International’s total shares outstanding.

Does Blackrock own Kiniksa Pharmaceuticals International?

BlackRock is not among the top 10 institutional shareholders of Kiniksa Pharmaceuticals International.

Who is Kiniksa Pharmaceuticals International’s biggest shareholder by percentage of total assets invested?

Spruce street capital lp is Kiniksa Pharmaceuticals International’s biggest shareholder by percentage of total assets invested, with 10.89% of its assets in 918.07K Kiniksa Pharmaceuticals International shares, valued at 68.5M$.

Who is the top mutual fund holder of Kiniksa Pharmaceuticals International shares?

Vanguard MStar Total Stk Mkt Idx Invest is the top mutual fund holder of Kiniksa Pharmaceuticals International shares, with 1.78% of its total shares outstanding invested in 1.39M Kiniksa Pharmaceuticals International shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools